ID

39891

Description

Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.; ODM derived from: https://clinicaltrials.gov/show/NCT01258439

Lien

https://clinicaltrials.gov/show/NCT01258439

Mots-clés

Versions (1)
  1. 29/02/2020 29/02/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

29 février 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility HIV NCT01258439

Anglais

Eligibility HIV NCT01258439

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility HIV NCT01258439
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
provision of signed, informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
age >18 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
hiv infection documented by hiv antibody test and western blot prior to study entry
Description

HIV Infections | HIV Antibody Measurement | Western blot for HIV

Type de données

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C3714540
UMLS CUI [3]
C0860963
no previous art or no art for 6 months prior to randomisation
Description

Antiretroviral therapy Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C1963724
UMLS CUI [1,2]
C0332197
cd4+ count of <500 cells/mm or viral load >10,000 copies/ml within 60 days prior to randomisation
Description

CD4+ Count | Viral load measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0243009
UMLS CUI [2]
C1261478
no genotypic resistance to raltegravir, tenofovir/emtricitabine, darunavir, ritonavir
Description

Absence Resistance Genotypic Raltegravir | Absence Resistance Genotypic Tenofovir | Absence Resistance Genotypic Emtricitabine | Absence Resistance Genotypic Darunavir | Absence Resistance Genotypic Ritonavir

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C1514892
UMLS CUI [1,3]
C0017431
UMLS CUI [1,4]
C1871526
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C1514892
UMLS CUI [2,3]
C0017431
UMLS CUI [2,4]
C0384228
UMLS CUI [3,1]
C0332197
UMLS CUI [3,2]
C1514892
UMLS CUI [3,3]
C0017431
UMLS CUI [3,4]
C0909839
UMLS CUI [4,1]
C0332197
UMLS CUI [4,2]
C1514892
UMLS CUI [4,3]
C0017431
UMLS CUI [4,4]
C1435444
UMLS CUI [5,1]
C0332197
UMLS CUI [5,2]
C1514892
UMLS CUI [5,3]
C0017431
UMLS CUI [5,4]
C0292818
body mass index less than 30kg/m2
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
primary hiv infection within the last 6 months
Description

Primary HIV infection Recent

Type de données

boolean

Alias
UMLS CUI [1,1]
C1142553
UMLS CUI [1,2]
C0332185
active infection or opportunistic illness within the previous 30 days
Description

Communicable Disease Recent | Opportunistic Infection Recent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0332185
UMLS CUI [2,1]
C0029118
UMLS CUI [2,2]
C0332185
use of any medication contra-indicated with ritonavir-boosted darunavir or raltegravir
Description

Pharmaceutical Preparation Contraindicated Darunavir+Ritonavir | Pharmaceutical Preparation Contraindicated Raltegravir

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1444657
UMLS CUI [1,3]
C1976853
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C1444657
UMLS CUI [2,3]
C1871526
use of lipid-lowering therapy
Description

Lipid-lowering therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0585943
diabetes mellitus (fasting glucose >7.0mml/l or a prior diagnosis of diabetes)
Description

Diabetes Mellitus | Glucose measurement, fasting

Type de données

boolean

Alias
UMLS CUI [1]
C0011849
UMLS CUI [2]
C0202045
use of oral prednisolone > 7.5mg daily or equivalent
Description

Oral prednisolone U/day | Equivalent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0358513
UMLS CUI [1,2]
C0456683
UMLS CUI [2]
C0205163
pregnancy or breast feeding
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
proven hypersensitivity to one or more components of the study meal
Description

Hypersensitivity Component Study Meal

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1705248
UMLS CUI [1,3]
C0008972
UMLS CUI [1,4]
C1998602
Retour au début de la page

Similar models

Eligibility HIV NCT01258439

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility HIV NCT01258439
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
provision of signed, informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
age >18 years
boolean
C0001779 (UMLS CUI [1])
HIV Infections | HIV Antibody Measurement | Western blot for HIV
Item
hiv infection documented by hiv antibody test and western blot prior to study entry
boolean
C0019693 (UMLS CUI [1])
C3714540 (UMLS CUI [2])
C0860963 (UMLS CUI [3])
Antiretroviral therapy Absent
Item
no previous art or no art for 6 months prior to randomisation
boolean
C1963724 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
CD4+ Count | Viral load measurement
Item
cd4+ count of <500 cells/mm or viral load >10,000 copies/ml within 60 days prior to randomisation
boolean
C0243009 (UMLS CUI [1])
C1261478 (UMLS CUI [2])
Absence Resistance Genotypic Raltegravir | Absence Resistance Genotypic Tenofovir | Absence Resistance Genotypic Emtricitabine | Absence Resistance Genotypic Darunavir | Absence Resistance Genotypic Ritonavir
Item
no genotypic resistance to raltegravir, tenofovir/emtricitabine, darunavir, ritonavir
boolean
C0332197 (UMLS CUI [1,1])
C1514892 (UMLS CUI [1,2])
C0017431 (UMLS CUI [1,3])
C1871526 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C1514892 (UMLS CUI [2,2])
C0017431 (UMLS CUI [2,3])
C0384228 (UMLS CUI [2,4])
C0332197 (UMLS CUI [3,1])
C1514892 (UMLS CUI [3,2])
C0017431 (UMLS CUI [3,3])
C0909839 (UMLS CUI [3,4])
C0332197 (UMLS CUI [4,1])
C1514892 (UMLS CUI [4,2])
C0017431 (UMLS CUI [4,3])
C1435444 (UMLS CUI [4,4])
C0332197 (UMLS CUI [5,1])
C1514892 (UMLS CUI [5,2])
C0017431 (UMLS CUI [5,3])
C0292818 (UMLS CUI [5,4])
Body mass index
Item
body mass index less than 30kg/m2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Primary HIV infection Recent
Item
primary hiv infection within the last 6 months
boolean
C1142553 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Communicable Disease Recent | Opportunistic Infection Recent
Item
active infection or opportunistic illness within the previous 30 days
boolean
C0009450 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0029118 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
Pharmaceutical Preparation Contraindicated Darunavir+Ritonavir | Pharmaceutical Preparation Contraindicated Raltegravir
Item
use of any medication contra-indicated with ritonavir-boosted darunavir or raltegravir
boolean
C0013227 (UMLS CUI [1,1])
C1444657 (UMLS CUI [1,2])
C1976853 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C1444657 (UMLS CUI [2,2])
C1871526 (UMLS CUI [2,3])
Lipid-lowering therapy
Item
use of lipid-lowering therapy
boolean
C0585943 (UMLS CUI [1])
Diabetes Mellitus | Glucose measurement, fasting
Item
diabetes mellitus (fasting glucose >7.0mml/l or a prior diagnosis of diabetes)
boolean
C0011849 (UMLS CUI [1])
C0202045 (UMLS CUI [2])
Oral prednisolone U/day | Equivalent
Item
use of oral prednisolone > 7.5mg daily or equivalent
boolean
C0358513 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0205163 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hypersensitivity Component Study Meal
Item
proven hypersensitivity to one or more components of the study meal
boolean
C0020517 (UMLS CUI [1,1])
C1705248 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
C1998602 (UMLS CUI [1,4])
Retour au début de la page 

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial